Rossum, A.M.C. van

children indinavir sequence study repmp strain patient protein pneumoniae therapy infection element virus level group subtype haart treatment growth response immunodeficiency inhibitor baseline t-cell count substrate mycoplasma adult kinderen subtype 2 strains activity protease result change increase immunodeficiency virus infection recumge recombination antiretroviral plasma antiretroviral therapy 96 weeks month mycoplasma pneumoniae value virological range zidovudine pharmacokinetic concentration combination residue genitalium position fluenza reaction p 1 gene serum weight effect method assay repmp 4 elements difference protease inhibitors chapter repmp 5 elements protease inhibitor virologic variation number height genome disease 48 weeks cleavage analysis z-score ruvbfh compliance